KEREN THERAPEUTICS
Keren Therapeutics is harnessing the biology of a naturally occurring peptide hormone to restore muscle function in the context of several musculoskeletal and muscle wasting diseases. Using the same biological insights, Keren is also developing a therapeutic to counteract cognitive decline associated with age-related neurodegenerative conditions.
KEREN THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2017-01-01
Address:
New York, New York, United States
Country:
United States
Status:
Active
Total Funding:
0
Similar Organizations
Sarentis Therapeutics
Sarentis Therapeutics engages in the development of therapeutics for the treatment of pain.
Investors List
Kairos Ventures
Kairos Ventures investment in Venture Round - Keren Therapeutics